<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Know Your Numbers ‚Äî STI Transmission Risk Calculator</title>
    <link rel="preconnect" href="https://fonts.googleapis.com">
    <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
    <link href="https://fonts.googleapis.com/css2?family=JetBrains+Mono:wght@400;500;600&family=Outfit:wght@300;400;500;600;700&display=swap" rel="stylesheet">
    <link rel="stylesheet" href="styles.css">
    <script src="https://cdn.jsdelivr.net/npm/chart.js"></script>
    <script id="MathJax-script" async src="https://cdn.jsdelivr.net/npm/mathjax@3/es5/tex-mml-chtml.js"></script>
    <script src="sources.js"></script>
</head>
<body>
    <div class="grain-overlay"></div>
    
    <nav class="nav">
        <div class="nav-brand">
            <span class="nav-icon">üìä</span>
            <span class="nav-title">Know Your Numbers</span>
        </div>
        <div class="nav-links">
            <a href="#mission">Why This Exists</a>
            <a href="#calculator">Calculator</a>
            <a href="#testing">Testing Guide</a>
            <a href="#stis">STI Data</a>
            <a href="#methodology">Methodology</a>
        </div>
    </nav>

    <header class="hero">
        <div class="hero-content">
            <h1 class="hero-title">
                <span class="hero-title-line">The numbers your</span>
                <span class="hero-title-line accent">doctor won't tell you.</span>
            </h1>
            <p class="hero-subtitle">
                Evidence-based STI transmission probabilities. Interactive risk calculators. 
                Complete transparency in methodology. Make informed decisions about your sexual health.
            </p>
            <div class="hero-cta">
                <a href="#calculator" class="btn btn-primary">Calculate Your Risk</a>
                <a href="#stis" class="btn btn-secondary">Browse STI Data</a>
            </div>
        </div>
        <div class="hero-visual">
            <div class="stat-preview">
                <div class="stat-card">
                    <span class="stat-number">6</span>
                    <span class="stat-label">STIs Covered</span>
                </div>
<div class="stat-card">
                                    <span class="stat-number">13</span>
                                    <span class="stat-label">Studies Cited</span>
                                </div>
                <div class="stat-card">
                    <span class="stat-number">‚àû</span>
                    <span class="stat-label">Scenarios</span>
                </div>
            </div>
        </div>
    </header>

    <section id="mission" class="section mission-section">
        <div class="container">
            <div class="section-header">
                <span class="section-tag">The Problem</span>
                <h2>Why I Built This</h2>
            </div>
            <div class="mission-content">
                <div class="mission-text">
                    <p class="lead">
                        I'm frustrated. Every time I ask a doctor about STI transmission probabilities, 
                        I get the same non-answers: "Use a condom and you'll be fine" or "Don't worry about it."
                    </p>
                    <p>
                        That's not good enough. If I have a partner with an STI, I want to know the <em>actual numbers</em>. 
                        What's my probability of transmission per encounter? How does that change with condom use? 
                        What if we're together for a year versus a month?
                    </p>
                    <p>
                        Doctors seem to operate on a culture of managed information ‚Äî deciding what you 
                        "need to know" rather than giving you the data to make your own informed decisions. 
                        With HPV, for example, the medical establishment has largely planned for it to spread 
                        through the population rather than helping individuals understand and manage their risk.
                    </p>
                    <p>
                        <strong>This site changes that.</strong> Every number here comes from peer-reviewed studies. 
                        Every calculation is transparent. You can see the equations, adjust the variables, 
                        and understand exactly how your risk is computed.
                    </p>
                    <p class="disclaimer">
                        <strong>Disclaimer:</strong> This is not medical advice. This is mathematical modeling 
                        based on published research. Consult healthcare providers for personal medical decisions.
                    </p>
                </div>
                <div class="mission-principles">
                    <h3>Our Principles</h3>
                    <ul class="principles-list">
                        <li>
                            <span class="principle-icon">üìö</span>
                            <div>
                                <strong>Cite Everything</strong>
                                <p>Every transmission rate links to its source study</p>
                            </div>
                        </li>
                        <li>
                            <span class="principle-icon">üî¢</span>
                            <div>
                                <strong>Show the Math</strong>
                                <p>All equations displayed in notation and code</p>
                            </div>
                        </li>
                        <li>
                            <span class="principle-icon">üéõÔ∏è</span>
                            <div>
                                <strong>Your Variables</strong>
                                <p>Customize calculations to your situation</p>
                            </div>
                        </li>
                        <li>
                            <span class="principle-icon">‚ö†Ô∏è</span>
                            <div>
                                <strong>Honest Uncertainty</strong>
                                <p>We show confidence intervals, not false precision</p>
                            </div>
                        </li>
                    </ul>
                </div>
            </div>
        </div>
    </section>

    <section id="calculator" class="section calculator-section">
        <div class="container">
            <div class="section-header">
                <span class="section-tag">Interactive Tool</span>
                <h2>Risk Calculator</h2>
                <p class="section-desc">
                    Select an STI, input your scenario, and see your cumulative risk over time.
                </p>
            </div>
            
            <div class="calculator-grid">
                <div class="calculator-inputs">
                    <div class="input-group">
                        <label for="sti-select">Select STI</label>
                        <select id="sti-select">
                            <option value="hiv">HIV</option>
                            <option value="hsv2">Herpes (HSV-2)</option>
                            <option value="hpv">HPV</option>
                            <option value="chlamydia" selected>Chlamydia</option>
                            <option value="gonorrhea">Gonorrhea</option>
                            <option value="syphilis">Syphilis</option>
                        </select>
                    </div>
                    
                    <div class="input-group">
                        <label for="direction-select">Transmission Direction</label>
                        <select id="direction-select">
                            <option value="mtf">Male ‚Üí Female (Vaginal)</option>
                            <option value="ftm">Female ‚Üí Male (Vaginal)</option>
                        </select>
                    </div>
                    
                    <div class="input-group">
                        <label for="frequency-input">
                            Sex frequency per week: <span id="frequency-value">2</span>
                        </label>
                        <input type="range" id="frequency-input" min="1" max="21" value="2" step="1">
                        <div class="range-labels">
                            <span>1√ó/week</span>
                            <span>Daily</span>
                            <span>3√ó/day</span>
                        </div>
                    </div>
                    
                    <div class="input-group">
                        <label for="duration-input">
                            Time period: <span id="duration-value">12</span> months
                        </label>
                        <input type="range" id="duration-input" min="1" max="60" value="12" step="1">
                        <div class="range-labels">
                            <span>1 month</span>
                            <span>5 years</span>
                        </div>
                    </div>

                    <div class="current-rate-display">
                        <div class="rate-section-title">Per-Act Transmission Rate</div>
                        <div class="rate-comparison">
                            <div class="rate-item">
                                <span class="rate-label">Without condom:</span>
                                <span class="rate-value" id="per-act-rate">--</span>
                            </div>
                            <div class="rate-item">
                                <span class="rate-label">With condom:</span>
                                <span class="rate-value-group">
                                    <span class="rate-reduction" id="rate-reduction"></span>
                                    <span class="rate-value" id="adjusted-rate">--</span>
                                </span>
                            </div>
                        </div>
                        </div>
                </div>
                
                <div class="calculator-output">
                    <div class="chart-container">
                        <canvas id="risk-chart"></canvas>
                    </div>
                    <div class="result-summary">
                        <div class="result-main">
                            <span class="result-label">Cumulative risk after <span id="result-duration">12</span> months:</span>
                            <span class="result-value" id="result-probability">--</span>
                        </div>
                        <div class="result-explanation">
                            <p id="result-explanation-text"></p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

    <section id="testing" class="section testing-section">
        <div class="container">
            <div class="section-header">
                <span class="section-tag">Take Action</span>
                <h2>Testing Guide</h2>
                <p class="section-desc">
                    Know when to test, what to ask for, and what a "standard panel" actually includes.
                </p>
            </div>

            <div class="testing-content">
                <div class="testing-block">
                    <h3>üïê Window Periods</h3>
                    <p class="testing-intro">
                        You can't test the day after exposure. Each STI has a <strong>window period</strong> ‚Äî 
                        the time between infection and when a test can detect it. Testing too early = false negative.
                    </p>
                    <table class="testing-table">
                        <thead>
                            <tr>
                                <th>STI</th>
                                <th>Window Period</th>
                                <th>Test Type</th>
                            </tr>
                        </thead>
                        <tbody>
                            <tr>
                                <td>HIV</td>
                                <td>2‚Äì6 weeks (4th gen test); 3 months (conclusive)</td>
                                <td>Blood</td>
                            </tr>
                            <tr>
                                <td>Chlamydia</td>
                                <td>1‚Äì2 weeks</td>
                                <td>Urine or swab</td>
                            </tr>
                            <tr>
                                <td>Gonorrhea</td>
                                <td>1‚Äì2 weeks</td>
                                <td>Urine or swab</td>
                            </tr>
                            <tr>
                                <td>Syphilis</td>
                                <td>3‚Äì6 weeks</td>
                                <td>Blood</td>
                            </tr>
                            <tr>
                                <td>Herpes (HSV)</td>
                                <td>4‚Äì6 weeks (antibodies); immediate if active sore</td>
                                <td>Blood or swab</td>
                            </tr>
                            <tr>
                                <td>HPV</td>
                                <td>No routine test for most people</td>
                                <td>Pap smear (cervix-havers only)</td>
                            </tr>
                        </tbody>
                    </table>
                </div>
            </div>
        </div>
    </section>

    <section id="stis" class="section stis-section">
        <div class="container">
            <div class="section-header">
                <span class="section-tag">The Data</span>
                <h2>STI Profiles</h2>
                <p class="section-desc">
                    Click any STI for detailed transmission data, risk factors, and sources.
                </p>
            </div>

            <div class="classification-legend">
                <p class="legend-intro">Each STI shows three key facts: how long it lasts, what happens without treatment, and what happens with treatment.</p>
                <div class="legend-grid">
                    <div class="legend-col">
                        <h4>Duration</h4>
                        <ul>
                            <li><strong>Curable</strong> ‚Äî Gone after treatment</li>
                            <li><strong>Usually Clears</strong> ‚Äî Body fights it off</li>
                            <li><strong>Chronic</strong> ‚Äî Lifelong</li>
                        </ul>
                    </div>
                    <div class="legend-col">
                        <h4>If Untreated</h4>
                        <ul>
                            <li>What happens if you ignore it</li>
                            <li>Ranges from mild to <strong>life-threatening</strong></li>
                        </ul>
                    </div>
                    <div class="legend-col">
                        <h4>With Treatment / Prevention</h4>
                        <ul>
                            <li>What happens when you take action</li>
                            <li>Usually <strong>much better</strong> than untreated</li>
                        </ul>
                    </div>
                </div>
            </div>
            
            <div class="sti-grid">
                <!-- HIV -->
                <article class="sti-card" id="sti-hiv">
                    <div class="sti-header">
                        <h3>HIV</h3>
                    </div>
                    <div class="sti-outlook">
                        <div class="outlook-item">
                            <span class="outlook-label">Duration</span>
                            <span class="outlook-value chronic">Chronic</span>
                        </div>
                        <div class="outlook-item">
                            <span class="outlook-label">If Untreated</span>
                            <span class="outlook-value critical">Fatal (AIDS)</span>
                        </div>
                        <div class="outlook-item">
                            <span class="outlook-label">With Treatment</span>
                            <span class="outlook-value positive">Normal lifespan</span>
                        </div>
                    </div>
                    <div class="sti-quick-facts">
                        <ul>
                            <li>üî¨ Low per-act transmission but serious consequences</li>
                            <li>üíä Antiretroviral treatment makes viral load undetectable = untransmittable</li>
                            <li>üõ°Ô∏è Condoms reduce risk by 80%</li>
                            <li>üíâ PrEP reduces risk by ~99% when taken daily</li>
                            <li>‚ö†Ô∏è Higher risk with other STIs present (inflammation)</li>
                        </ul>
                    </div>
                    <div class="sti-rates">
                        <h4>Transmission Rates (per vaginal sex act)</h4>
                        <table class="rates-table">
                            <thead>
                                <tr>
                                    <th>Direction</th>
                                    <th>No Condom</th>
                                    <th>Condom Effectiveness</th>
                                </tr>
                            </thead>
                            <tbody>
                                <tr>
                                    <td>Male ‚Üí Female</td>
                                    <td><span class="citable" data-source="hiv_cdc_risk_estimates">0.08%<span class="cite-tooltip"><span class="cite-tooltip-source">CDC HIV Risk and Prevention Estimates</span><span class="cite-tooltip-quote">"Risk per 10,000 exposures ... Receptive penile-vaginal intercourse ... 8"</span><a href="https://www.cdc.gov/hivpartners/php/riskandprevention/index.html#:~:text=Risk%20per%2010%2C000%20exposures" target="_blank" class="cite-tooltip-link">View Source ‚Üí</a></span></span></td>
                                    <td rowspan="2"><span class="citable" data-source="hiv_condom_effectiveness">80% reduction<span class="cite-tooltip"><span class="cite-tooltip-source">CDC HIV Risk and Prevention Estimates</span><span class="cite-tooltip-quote">"Always using condoms, based on self-report, during sex with an HIV-positive partner reduces the risk of HIV acquisition by an estimated 80% among heterosexual men and women"</span><a href="https://www.cdc.gov/hivpartners/php/riskandprevention/index.html#:~:text=Always%20using%20condoms%2C%20based%20on%20self-report%2C%20during%20sex%20with%20an%20HIV-positive%20partner%20reduces%20the%20risk%20of%20HIV%20acquisition%20by%20an%20estimated%2080%25" target="_blank" class="cite-tooltip-link">View Source ‚Üí</a></span></span></td>
                                </tr>
                                <tr>
                                    <td>Female ‚Üí Male</td>
                                    <td><span class="citable" data-source="hiv_cdc_risk_estimates">0.04%<span class="cite-tooltip"><span class="cite-tooltip-source">CDC HIV Risk and Prevention Estimates</span><span class="cite-tooltip-quote">"Risk per 10,000 exposures ... Insertive penile-vaginal intercourse ... 4"</span><a href="https://www.cdc.gov/hivpartners/php/riskandprevention/index.html#:~:text=Risk%20per%2010%2C000%20exposures" target="_blank" class="cite-tooltip-link">View Source ‚Üí</a></span></span></td>
                                </tr>
                            </tbody>
                        </table>
                    </div>
                    <details class="sti-details">
                        <summary>Key Context</summary>
                        <div class="details-content">
                            <p>
                                HIV transmission probability varies significantly based on viral load, presence of other STIs, 
                                and stage of infection. The rates above assume a partner with detectable (untreated) HIV. 
                                Partners on effective antiretroviral therapy with undetectable viral load have essentially 
                                zero transmission risk (U=U: Undetectable = Untransmittable).
                            </p>
                            <p>
                                <strong>PrEP:</strong> Pre-exposure prophylaxis reduces risk by ~99% when taken daily.
                                <strong>PEP:</strong> Post-exposure prophylaxis can prevent infection if started within 72 hours.
                            </p>
                        </div>
                    </details>
                </article>

                <!-- HSV-2 -->
                <article class="sti-card" id="sti-hsv2">
                    <div class="sti-header">
                        <h3>Herpes (HSV-2)</h3>
                    </div>
                    <div class="sti-outlook">
                        <div class="outlook-item">
                            <span class="outlook-label">Duration</span>
                            <span class="outlook-value chronic">Chronic</span>
                        </div>
                        <div class="outlook-item">
                            <span class="outlook-label">If Untreated</span>
                            <span class="outlook-value low">Periodic outbreaks</span>
                        </div>
                        <div class="outlook-item">
                            <span class="outlook-label">With Treatment</span>
                            <span class="outlook-value positive">Rare/no outbreaks</span>
                        </div>
                    </div>
                    <div class="sti-quick-facts">
                        <ul>
                            <li>üîÑ Transmits via skin-to-skin contact, not just fluids</li>
                            <li>üò∂ Most people are asymptomatic or have mild symptoms</li>
                            <li>üõ°Ô∏è Condoms reduce risk by 96% M‚ÜíF, 65% F‚ÜíM</li>
                            <li>üíä Daily antivirals (e.g., valacyclovir) reduce transmission by ~50%</li>
                            <li>üìÖ Avoiding sex during outbreaks significantly reduces risk</li>
                        </ul>
                    </div>
                    <div class="sti-rates">
                        <h4>Transmission Rates (per vaginal sex act)</h4>
                        <table class="rates-table">
                            <thead>
                                <tr>
                                    <th>Direction</th>
                                    <th>No Condom</th>
                                    <th>Condom Effectiveness</th>
                                </tr>
                            </thead>
                            <tbody>
                                <tr>
                                    <td>Male ‚Üí Female</td>
                                    <td><span class="citable" data-source="hsv2_per_act_derived">0.053%<span class="cite-tooltip"><span class="cite-tooltip-source">Corey et al. 2004 (NEJM) ‚Äî Derived</span><span class="cite-tooltip-quote">"The overall rate of transmission of HSV-2 was 3.6 per 100 person-years" ‚Äî Derived to per-act assuming ~70 acts over 8-month study period</span><a href="https://pubmed.ncbi.nlm.nih.gov/14702423/#:~:text=overall%20rate%20of%20transmission%20of%20HSV-2%20was%203.6%20per%20100%20person-years" target="_blank" class="cite-tooltip-link">View Source ‚Üí</a></span></span></td>
                                    <td><span class="citable" data-source="hsv2_condom_effectiveness">96% reduction<span class="cite-tooltip"><span class="cite-tooltip-source">Martin et al. 2009 (PMC) ‚Äî From Table 1</span><span class="cite-tooltip-quote">Table 1: "Use of condoms" ‚Üí Risk Ratio = 0.04 for susceptible women (1 - 0.04 = 96% reduction)</span><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4725379/" target="_blank" class="cite-tooltip-link">View Source ‚Üí</a><span class="cite-tooltip-warning">‚ö†Ô∏è Data from table, not prose text</span></span></span></td>
                                </tr>
                                <tr>
                                    <td>Female ‚Üí Male</td>
                                    <td><span class="citable" data-source="hsv2_per_act_derived">0.053%<span class="cite-tooltip"><span class="cite-tooltip-source">Corey et al. 2004 (NEJM) ‚Äî Derived</span><span class="cite-tooltip-quote">"The overall rate of transmission of HSV-2 was 3.6 per 100 person-years" ‚Äî Derived to per-act (study didn't distinguish direction)</span><a href="https://pubmed.ncbi.nlm.nih.gov/14702423/#:~:text=overall%20rate%20of%20transmission%20of%20HSV-2%20was%203.6%20per%20100%20person-years" target="_blank" class="cite-tooltip-link">View Source ‚Üí</a></span></span></td>
                                    <td><span class="citable" data-source="hsv2_condom_effectiveness">65% reduction<span class="cite-tooltip"><span class="cite-tooltip-source">Martin et al. 2009 (PMC) ‚Äî From Table 1</span><span class="cite-tooltip-quote">Table 1: "Use of condoms" ‚Üí Risk Ratio = 0.35 for susceptible men (1 - 0.35 = 65% reduction)</span><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4725379/" target="_blank" class="cite-tooltip-link">View Source ‚Üí</a><span class="cite-tooltip-warning">‚ö†Ô∏è Data from table; p=.060 (not statistically significant)</span></span></span></td>
                                </tr>
                            </tbody>
                        </table>
                        <p class="rate-note">
                            Note: Per-act rate derived from 8-month study. HSV-2 sheds asymptomatically, so transmission 
                            can occur without visible sores. Daily antivirals reduce transmission by ~50% on top of condoms.
                        </p>
                    </div>
                    <details class="sti-details">
                        <summary>Key Context</summary>
                        <div class="details-content">
                            <p>
                                HSV-2 transmission is complex because the virus sheds asymptomatically. Even without visible 
                                sores, transmission can occur. Avoiding sex during outbreaks significantly reduces risk.
                            </p>
                            <p>
                                <strong>Daily antivirals</strong> (e.g., valacyclovir) reduce transmission by ~50% on top of condom use.
                                Most people with HSV-2 are asymptomatic or have mild symptoms they don't recognize as herpes.
                            </p>
                        </div>
                    </details>
                </article>

                <!-- HPV -->
                <article class="sti-card" id="sti-hpv">
                    <div class="sti-header">
                        <h3>HPV (Human Papillomavirus)</h3>
                    </div>
                    <div class="sti-outlook">
                        <div class="outlook-item">
                            <span class="outlook-label">Duration</span>
                            <span class="outlook-value clears">Usually clears on its own</span>
                        </div>
                        <div class="outlook-item">
                            <span class="outlook-label">If Untreated</span>
                            <span class="outlook-value moderate">Some strains cause cancer</span>
                        </div>
                        <div class="outlook-item">
                            <span class="outlook-label">Prevention</span>
                            <span class="outlook-value positive">Vaccine highly effective</span>
                        </div>
                    </div>
                    <div class="sti-quick-facts">
                        <ul>
                            <li>üìä Most sexually active people get HPV at some point</li>
                            <li>üß¨ 200+ strains; most are harmless, some cause cancer</li>
                            <li>üõ°Ô∏è Condoms reduce risk by 70% with consistent use</li>
                            <li>üíâ Vaccine prevents the most dangerous strains</li>
                            <li>‚è≥ 90% of infections clear within 2 years</li>
                        </ul>
                    </div>
                    <div class="sti-rates">
                        <h4>Transmission Rates (per vaginal sex act)</h4>
                        <table class="rates-table">
                            <thead>
                                <tr>
                                    <th>Direction</th>
                                    <th>No Condom</th>
                                    <th>Condom Effectiveness</th>
                                </tr>
                            </thead>
                            <tbody>
                                <tr>
                                    <td>Male ‚Üí Female</td>
                                    <td><span class="citable" data-source="hpv_hitch_2021">0.41%<span class="cite-tooltip"><span class="cite-tooltip-source">Malag√≥n et al. 2021 (HITCH cohort) ‚Äî Derived</span><span class="cite-tooltip-quote">"The transmission rate from men to women was 3.5 ... per 100 person‚Äìmonths"</span><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC8012224/#:~:text=from%20men%20to%20women%20was%203.5" target="_blank" class="cite-tooltip-link">View Source ‚Üí</a></span></span></td>
                                    <td rowspan="2"><span class="citable" data-source="hpv_condom_effectiveness">70% reduction<span class="cite-tooltip"><span class="cite-tooltip-source">MDedge / Winer et al.</span><span class="cite-tooltip-quote">"Women whose sexual partners consistently used condoms were 70% less likely to acquire genital human papillomavirus infection"</span><a href="https://community.the-hospitalist.org/content/condoms-found-prevent-hpv-transmission#:~:text=70%25%20less%20likely%20to%20acquire%20genital%20human%20papillomavirus%20infection" target="_blank" class="cite-tooltip-link">View Source ‚Üí</a></span></span></td>
                                </tr>
                                <tr>
                                    <td>Female ‚Üí Male</td>
                                    <td><span class="citable" data-source="hpv_hitch_2021">0.66%<span class="cite-tooltip"><span class="cite-tooltip-source">Malag√≥n et al. 2021 (HITCH cohort) ‚Äî Derived</span><span class="cite-tooltip-quote">"... from women to men was 5.6 (95%PI 3.8‚Äì7.0) per 100 person‚Äìmonths ... rate ratio of 1.6 (95%PI 1.0‚Äì2.5)"</span><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC8012224/#:~:text=5.6%20(95%25PI%203.8%E2%80%937.0)%20per%20100%20person%E2%80%93months" target="_blank" class="cite-tooltip-link">View Source ‚Üí</a></span></span></td>
                                </tr>
                            </tbody>
                        </table>
                        <p class="rate-note">
                            Per-act rates derived from person-month data. HPV is highly variable ‚Äî most sexually active 
                            people get it at some point. Vaccine is the most effective prevention.
                        </p>
                    </div>
                    <details class="sti-details">
                        <summary>Key Context</summary>
                        <div class="details-content">
                            <p>
                                HPV is unique because it's so common that "preventing" it may be unrealistic for 
                                sexually active adults who aren't vaccinated. The medical establishment's approach 
                                has largely been to expect exposure and rely on the immune system to clear it.
                            </p>
                            <p>
                                <strong>The key questions:</strong> (1) Are you vaccinated? (2) Are you getting regular 
                                screenings (Pap smears for cervix-havers)? The vaccine prevents the strains that cause 
                                most cancers and genital warts.
                            </p>
                        </div>
                    </details>
                </article>

                <!-- Chlamydia -->
                <article class="sti-card" id="sti-chlamydia">
                    <div class="sti-header">
                        <h3>Chlamydia</h3>
                    </div>
                    <div class="sti-outlook">
                        <div class="outlook-item">
                            <span class="outlook-label">Duration</span>
                            <span class="outlook-value curable">Curable</span>
                        </div>
                        <div class="outlook-item">
                            <span class="outlook-label">If Untreated</span>
                            <span class="outlook-value moderate">PID, infertility risk</span>
                        </div>
                        <div class="outlook-item">
                            <span class="outlook-label">With Treatment</span>
                            <span class="outlook-value positive">Cured, no lasting effects</span>
                        </div>
                    </div>
                    <div class="sti-quick-facts">
                        <ul>
                            <li>ü¶† Most common bacterial STI</li>
                            <li>üò∂ ~70% of women and 50% of men have no symptoms</li>
                            <li>üíä Easily cured with antibiotics (usually azithromycin)</li>
                            <li>üõ°Ô∏è Condoms reduce risk by 60%</li>
                            <li>‚ö†Ô∏è Untreated can cause PID, infertility</li>
                        </ul>
                    </div>
                    <div class="sti-rates">
                        <h4>Transmission Rates (per vaginal sex act)</h4>
                        <table class="rates-table">
                            <thead>
                                <tr>
                                    <th>Direction</th>
                                    <th>No Condom</th>
                                    <th>Condom Effectiveness</th>
                                </tr>
                            </thead>
                            <tbody>
                                <tr>
                                    <td>Male ‚Üí Female</td>
                                    <td><span class="citable" data-source="chlamydia_ncbi_per_act">11.4%<span class="cite-tooltip"><span class="cite-tooltip-source">NCBI Book NBK261441 ‚Äî Derived</span><span class="cite-tooltip-quote">"the per-sex act transmission probability for chlamydia ... is in the range 6‚Äì16.7%" ‚Äî Midpoint: 11.4%</span><a href="https://www.ncbi.nlm.nih.gov/books/NBK261441/#:~:text=per-sex%20act%20transmission%20probability%20for%20chlamydia" target="_blank" class="cite-tooltip-link">View Source ‚Üí</a></span></span></td>
                                    <td rowspan="2"><span class="citable" data-source="chlamydia_condom_effectiveness">60% reduction<span class="cite-tooltip"><span class="cite-tooltip-source">Crosby et al. 2004 (JAMA Pediatrics)</span><span class="cite-tooltip-quote">"We found that correct and consistent use of condoms reduced the risk of chlamydial infection by 60%"</span><a href="https://jamanetwork.com/journals/jamapediatrics/fullarticle/486033#:~:text=correct%20and%20consistent%20use%20of%20condoms%20reduced%20the%20risk%20of%20chlamydial%20infection%20by%2060%25" target="_blank" class="cite-tooltip-link">View Source ‚Üí</a></span></span></td>
                                </tr>
                                <tr>
                                    <td>Female ‚Üí Male</td>
                                    <td><span class="citable" data-source="chlamydia_ncbi_per_act">11.4%<span class="cite-tooltip"><span class="cite-tooltip-source">NCBI Book NBK261441 ‚Äî Derived</span><span class="cite-tooltip-quote">"the per-sex act transmission probability for chlamydia ... is in the range 6‚Äì16.7%" ‚Äî Midpoint (no M‚ÜíF vs F‚ÜíM distinction in source)</span><a href="https://www.ncbi.nlm.nih.gov/books/NBK261441/#:~:text=per-sex%20act%20transmission%20probability%20for%20chlamydia" target="_blank" class="cite-tooltip-link">View Source ‚Üí</a></span></span></td>
                                </tr>
                            </tbody>
                        </table>
                        <p class="rate-note">
                            Per-act rate is midpoint of 6-17% range. Source does not distinguish M‚ÜíF vs F‚ÜíM.
                        </p>
                    </div>
                    <details class="sti-details">
                        <summary>Key Context</summary>
                        <div class="details-content">
                            <p>
                                Chlamydia is extremely common and often asymptomatic, which is why routine testing 
                                is recommended. It's easily treated but can cause serious complications if left untreated
                                (pelvic inflammatory disease, infertility).
                            </p>
                            <p>
                                <strong>Testing:</strong> Recommended annually for sexually active women under 25 and anyone 
                                with new or multiple partners. Treatment is simple: a single dose of azithromycin or a week of doxycycline.
                            </p>
                        </div>
                    </details>
                </article>

                <!-- Gonorrhea -->
                <article class="sti-card" id="sti-gonorrhea">
                    <div class="sti-header">
                        <h3>Gonorrhea</h3>
                    </div>
                    <div class="sti-outlook">
                        <div class="outlook-item">
                            <span class="outlook-label">Duration</span>
                            <span class="outlook-value curable">Curable</span>
                        </div>
                        <div class="outlook-item">
                            <span class="outlook-label">If Untreated</span>
                            <span class="outlook-value moderate">Spreads, infertility risk</span>
                        </div>
                        <div class="outlook-item">
                            <span class="outlook-label">With Treatment</span>
                            <span class="outlook-value positive">Cured, no lasting effects</span>
                        </div>
                    </div>
                    <div class="sti-quick-facts">
                        <ul>
                            <li>ü¶† Second most common bacterial STI</li>
                            <li>‚ö†Ô∏è Increasing antibiotic resistance is a global concern</li>
                            <li>üíä Current treatment: ceftriaxone injection + azithromycin</li>
                            <li>üõ°Ô∏è Condoms reduce risk by 90%</li>
                            <li>üî• More likely to cause symptoms than chlamydia (burning, discharge)</li>
                        </ul>
                    </div>
                    <div class="sti-rates">
                        <h4>Transmission Rates (per vaginal sex act)</h4>
                        <table class="rates-table">
                            <thead>
                                <tr>
                                    <th>Direction</th>
                                    <th>No Condom</th>
                                    <th>Condom Effectiveness</th>
                                </tr>
                            </thead>
                            <tbody>
                                <tr>
                                    <td>Male ‚Üí Female</td>
                                    <td><span class="citable" data-source="gonorrhea_ncbi_book">22.8%<span class="cite-tooltip"><span class="cite-tooltip-source">NCBI Book NBK261441 ‚Äî Derived</span><span class="cite-tooltip-quote">"the per-sex act transmission probability for gonorrhoea is assumed to be twice that of chlamydia" (chlamydia 6-16.7%, midpoint 11.4% √ó 2 = 22.8%)</span><a href="https://www.ncbi.nlm.nih.gov/books/NBK261441/#:~:text=per-sex%20act%20transmission%20probability%20for%20gonorrhoea%20is%20assumed%20to%20be%20twice%20that%20of%20chlamydia" target="_blank" class="cite-tooltip-link">View Source ‚Üí</a></span></span></td>
                                    <td rowspan="2"><span class="citable" data-source="gonorrhea_condom_effectiveness">90% reduction<span class="cite-tooltip"><span class="cite-tooltip-source">Crosby et al. 2004 (JAMA Pediatrics)</span><span class="cite-tooltip-quote">"We found that correct and consistent use of condoms reduced the risk of gonorrhea by 90%"</span><a href="https://jamanetwork.com/journals/jamapediatrics/fullarticle/486033#:~:text=correct%20and%20consistent%20use%20of%20condoms%20reduced%20the%20risk%20of%20gonorrhea%20by%2090%25" target="_blank" class="cite-tooltip-link">View Source ‚Üí</a></span></span></td>
                                </tr>
                                <tr>
                                    <td>Female ‚Üí Male</td>
                                    <td><span class="citable" data-source="gonorrhea_ncbi_book">22.8%<span class="cite-tooltip"><span class="cite-tooltip-source">NCBI Book NBK261441 ‚Äî Derived</span><span class="cite-tooltip-quote">"the per-sex act transmission probability for gonorrhoea is assumed to be twice that of chlamydia" ‚Äî Source does not distinguish M‚ÜíF vs F‚ÜíM</span><a href="https://www.ncbi.nlm.nih.gov/books/NBK261441/#:~:text=per-sex%20act%20transmission%20probability%20for%20gonorrhoea%20is%20assumed%20to%20be%20twice%20that%20of%20chlamydia" target="_blank" class="cite-tooltip-link">View Source ‚Üí</a></span></span></td>
                                </tr>
                            </tbody>
                        </table>
                        <p class="rate-note">
                            Per-act rate derived from 2√ó chlamydia. Source does not distinguish M‚ÜíF vs F‚ÜíM.
                        </p>
                    </div>
                    <details class="sti-details">
                        <summary>Key Context</summary>
                        <div class="details-content">
                            <p>
                                Gonorrhea is highly infectious ‚Äî even a single unprotected encounter carries significant risk.
                                Unlike chlamydia, gonorrhea often causes noticeable symptoms (burning, discharge).
                            </p>
                            <p>
                                <strong>Antibiotic resistance</strong> is a growing concern. Current treatment requires a 
                                ceftriaxone injection. If you've had gonorrhea, get retested 3 months after treatment to 
                                ensure it's cleared and you haven't been reinfected.
                            </p>
                        </div>
                    </details>
                </article>

                <!-- Syphilis -->
                <article class="sti-card" id="sti-syphilis">
                    <div class="sti-header">
                        <h3>Syphilis</h3>
                    </div>
                    <div class="sti-outlook">
                        <div class="outlook-item">
                            <span class="outlook-label">Duration</span>
                            <span class="outlook-value curable">Curable</span>
                        </div>
                        <div class="outlook-item">
                            <span class="outlook-label">If Untreated</span>
                            <span class="outlook-value serious">Organ damage, death</span>
                        </div>
                        <div class="outlook-item">
                            <span class="outlook-label">With Treatment</span>
                            <span class="outlook-value positive">Cured, no lasting effects</span>
                        </div>
                    </div>
                    <div class="sti-quick-facts">
                        <ul>
                            <li>üìà Cases are surging after decades of decline</li>
                            <li>üî¥ Primary stage: painless sore (chancre)</li>
                            <li>üíä Easily cured with penicillin</li>
                            <li>üõ°Ô∏è Condoms reduce risk by 50-71% (sores may be outside covered area)</li>
                            <li>‚ö†Ô∏è Untreated can cause serious organ damage years later</li>
                        </ul>
                    </div>
                    <div class="sti-rates">
                        <h4>Transmission Rates (per vaginal sex act)</h4>
                        <table class="rates-table">
                            <thead>
                                <tr>
                                    <th>Stage</th>
                                    <th>No Condom</th>
                                    <th>Condom Effectiveness</th>
                                </tr>
                            </thead>
                            <tbody>
                                <tr>
                                    <td>Early syphilis (primary, secondary, early latent)</td>
                                    <td><span class="citable" data-source="syphilis_ashm_per_act">&gt;20%<span class="cite-tooltip"><span class="cite-tooltip-source">ASHM Contact Tracing Guidelines</span><span class="cite-tooltip-quote">"The overall probability of transmission of syphilis during early infection is estimated to be greater than 20% per contact"</span><a href="https://contacttracing.ashm.org.au/syphilis/#:~:text=greater%20than%2020%25%20per%20contact" target="_blank" class="cite-tooltip-link">View Source ‚Üí</a></span></span></td>
                                    <td rowspan="2"><span class="citable" data-source="syphilis_condom_effectiveness">50-71% reduction<span class="cite-tooltip"><span class="cite-tooltip-source">PMC4660551 ‚Äî Condom Review</span><span class="cite-tooltip-quote">"Syphilis transmission is reduced 29% for typical use. It is reduced 50‚Äì71% when condoms are used 100% of the time correctly."</span><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4660551/#:~:text=Syphilis%20transmission%20is%20reduced%2029%25%20for%20typical%20use" target="_blank" class="cite-tooltip-link">View Source ‚Üí</a></span></span></td>
                                </tr>
                                <tr>
                                    <td>Latent stage</td>
                                    <td><span class="citable-unverified">Low<span class="unverified-tooltip">‚ö†Ô∏è Needs verification ‚Äî not well quantified in literature</span></span></td>
                                </tr>
                            </tbody>
                        </table>
                        <p class="rate-note">
                            Transmission depends heavily on stage. Primary/secondary stages are highly infectious. 
                            Condoms less effective than for other STIs because sores may be outside covered area.
                        </p>
                    </div>
                    <details class="sti-details">
                        <summary>Key Context</summary>
                        <div class="details-content">
                            <p>
                                Syphilis progresses through stages, and transmission risk varies dramatically. 
                                The primary chancre (sore) is the most infectious period. If you can see a sore, 
                                avoid contact ‚Äî that's when transmission is most likely.
                            </p>
                            <p>
                                <strong>Syphilis is resurging</strong> after decades of decline. Get tested if sexually active, 
                                especially with new partners. Treatment is simple: a penicillin injection cures it at any stage, 
                                though damage from late-stage syphilis cannot be reversed.
                            </p>
                        </div>
                    </details>
                </article>
            </div>
        </div>
    </section>

    <section id="methodology" class="section methodology-section">
        <div class="container">
            <div class="section-header">
                <span class="section-tag">Transparency</span>
                <h2>Methodology</h2>
                <p class="section-desc">
                    How we calculate transmission probabilities and where the numbers come from.
                </p>
            </div>
            
            <div class="methodology-content">
                <div class="method-block">
                    <h3>The Core Equation</h3>
                    <p>
                        All risk calculations use the same fundamental probability formula. 
                        If each exposure has independent risk \( r \), then after \( n \) exposures:
                    </p>
                    <div class="math-block large">
                        <p>\[ P_{transmission} = 1 - (1 - r)^n \]</p>
                    </div>
                    <p>Intuitively: we calculate the probability of <em>not</em> getting infected after each encounter, 
                    multiply them together, then subtract from 1.</p>
                    
                    <div class="code-block">
                        <h4>JavaScript Implementation</h4>
<pre><code>function calculateCumulativeRisk(perActRisk, numberOfEncounters) {
    // Probability of NOT being infected after all encounters
    const probNotInfected = Math.pow(1 - perActRisk, numberOfEncounters);
    
    // Probability of being infected = 1 - (prob of not infected)
    return 1 - probNotInfected;
}

// Example: Chlamydia (12.5% per act), 8 encounters
calculateCumulativeRisk(0.125, 8);  // Returns: 0.656 (65.6%)</code></pre>
                    </div>
                </div>
                
                <div class="method-block">
                    <h3>Adjusting for Condom Use</h3>
                    <p>
                        Condoms reduce transmission by a certain percentage, depending on the STI. 
                        We multiply the base risk by (1 - effectiveness):
                    </p>
                    <div class="math-block">
                        <p>\[ r_{protected} = r_{unprotected} \times (1 - e_{condom}) \]</p>
                    </div>
                    <div class="code-block">
<pre><code>function adjustForCondom(baseRisk, condomEffectiveness) {
    return baseRisk * (1 - condomEffectiveness);
}

// HIV: 0.08% base, 80% condom effectiveness
adjustForCondom(0.0008, 0.80);  // Returns: 0.00016 (0.016%)</code></pre>
                    </div>
                </div>

                <div class="method-block">
                    <h3>Limitations & Caveats</h3>
                    <div class="caveats-grid">
                        <div class="caveat">
                            <h4>üéØ Individual Variation</h4>
                            <p>Risk varies by viral load, inflammation, other infections, and biological factors. 
                            Population averages may not reflect your specific risk.</p>
                        </div>
                        <div class="caveat">
                            <h4>üìä Study Populations</h4>
                            <p>Studies often focus on specific populations (e.g., discordant couples, clinic attendees). 
                            Results may not generalize to all scenarios.</p>
                        </div>
                        <div class="caveat">
                            <h4>üîÑ Independence Assumption</h4>
                            <p>The formula assumes each encounter is independent. In reality, factors like 
                            mucosal trauma or co-infections can create dependencies.</p>
                        </div>
                        <div class="caveat">
                            <h4>üìÖ Data Age</h4>
                            <p>Some studies are older. HIV treatment has improved dramatically; resistance patterns 
                            change. We cite dates so you can assess currency.</p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

    <footer class="footer">
        <div class="container">
            <div class="footer-content">
                <div class="footer-main">
                    <h3>Know Your Numbers</h3>
                    <p>Transparent, data-driven sexual health information.</p>
                    <p class="footer-disclaimer">
                        This website provides educational information only and is not medical advice. 
                        Consult a healthcare provider for personal medical decisions.
                    </p>
                </div>
                <div class="footer-links">
                    <h4>Resources</h4>
                    <ul>
                        <li><a href="https://www.cdc.gov/sti/" target="_blank">CDC STI Homepage</a></li>
                        <li><a href="https://www.plannedparenthood.org/" target="_blank">Planned Parenthood</a></li>
                        <li><a href="https://www.cdc.gov/sti/testing/index.html" target="_blank">Find Testing Near You</a></li>
                    </ul>
                </div>
                <div class="footer-links">
                    <h4>On This Site</h4>
                    <ul>
                        <li><a href="#mission">Why This Exists</a></li>
                        <li><a href="#calculator">Risk Calculator</a></li>
                        <li><a href="#methodology">Methodology</a></li>
                    </ul>
                </div>
            </div>
            <div class="footer-bottom">
                <p>Made with frustration and math. Open source on GitHub.</p>
            </div>
        </div>
    </footer>

    <script src="app.js"></script>
</body>
</html>
